CLINICAL_TRIALS
research
· 2017-01-11
Clinical Trial Update: The Aim of This Study is to Determine the Effectiveness of a Motivational Enhancement Intervention in Reducing Risk Behaviors (Drug and Alcohol Use, Sexual Risk Behavior, Poor Adherence to Medications) Among HIV+ Youth. - 1 [Phase 2]
Summary
A Phase 2 clinical trial sponsored by the National Institute on Drug Abuse (NIDA) is evaluating whether a motivational enhancement intervention can reduce risk …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Adherence, HIV Risk Behaviors | Phase 2 | Status: UNKNOWN